Patient-focused measures of functional health status and health-related quality of life in pediatric orthopedics: A case study in measurement selection

Health and Quality of Life Outcomes

Volumn 3, Issue , 2005, Pages

  Furlong, William ^a,b   Barr, Ronald D ^a,c   Feeny, David ^b,d,e   Yandow, Suzanne ^f  

^a MCMASTER UNIVERSITY   (Canada)

^b Health Utilities Incorporated   (Canada)

^c MCMASTER CHILDREN S HOSPITAL   (Canada)

^d INSTITUTE OF HEALTH ECONOMICS   (Canada)

^e UNIVERSITY OF ALBERTA   (Canada)

^f SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

Health status; Health related quality of life; Neurofibromatosis; Orthopedics; Pediatrics

Indexed keywords

BONE DISEASE; BONE DYSPLASIA; BONE TRANSPLANTATION; CAREGIVER; CASE STUDY; CHILD HEALTH; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; FUNCTIONAL ASSESSMENT; HIP INJURY; HUMAN; INFORMATION PROCESSING; INTRAMEDULLARY NAILING; MORBIDITY; NEUROFIBROMATOSIS; ORTHOPEDIC SURGERY; OUTCOMES RESEARCH; PEDIATRIC SURGERY; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; REVIEW; SCORING SYSTEM; TOTAL HIP PROSTHESIS; TREATMENT OUTCOME; VALIDATION PROCESS; ADOLESCENT; ARTICLE; CHILD; CUSTODY; DAILY LIFE ACTIVITY; DISCRIMINANT ANALYSIS; FEASIBILITY STUDY; FIBROUS DYSPLASIA; INFANT; INSTRUMENTATION; METHODOLOGY; OUTCOME ASSESSMENT; PARENT; PATIENT CARE; PRESCHOOL CHILD; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; SICKNESS IMPACT PROFILE; VALIDATION STUDY;

ACTIVITIES OF DAILY LIVING; ADOLESCENT; CHILD; CHILD, PRESCHOOL; DISCRIMINANT ANALYSIS; FEASIBILITY STUDIES; FIBROUS DYSPLASIA OF BONE; HUMANS; INFANT; NEUROFIBROMATOSIS 1; ORTHOPEDIC PROCEDURES; OUTCOME ASSESSMENT (HEALTH CARE); PARENTS; PATIENT-CENTERED CARE; PROXY; PSYCHOMETRICS; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; QUESTIONNAIRES; SICKNESS IMPACT PROFILE;

EID: 16344376361     PISSN: 14777525     EISSN: None     Source Type: Journal    
DOI: 10.1186/1477-7525-3-3     Document Type: Review

References (90)

1. Laupacis A, Rorabeck CH, Bourne RB, Feeny D, Tugwell P, Sim DA: Randomized Trials in Orthopaedics: Why, How and When. J Bone Joint Surgery 1989, 71:535-543.
2. Matza LS, Swensen AR, Flood EM, Secnik K, Leidy NK: Assessment of health-related quality of life in children: a review of conceptual, methodological and regulatory issues. Value Health 2004, 7:79-92.
3. Patrick DL, Erickson P: Health Status and Health Policy: quality of life in health care evaluation and resource allocation New York: Oxford University Press; 1993.
4. Guyatt GH, Naylor CD, Juniper E, Heyland DK, Jaeschke R, Cook DJ: Users' Guide to the Medical Literature XII. How to Use Articles About Health-Related Quality of Life. JAMA 1997, 277: 232-1237.
5. Steinwachs DM, Wu AW, Cagney KA: Outcome research and quality of care. In Quality of Life and Pharmacoeconomics in Clinical Trials Second edition. Edited by: Spilker B. Philadelphia: Lippincott-Raven Press; 1996:747-752.
6. Osoba D: Health-related quality-of-life outcomes in clinical trials. In Assessing Quality of Life in Clinical Trials Edited by: Fayers P, Hayes RD. Oxford: Oxford University Press; 2004:259-274.
7. Guyatt GH, Feeny DH, Patrick DL: Measuring health-related quality of life. Ann Intern Med 1993, 118:622-629.
8. Rorabeck CH, Bourne RB, Laupacis A, Feeny D, Wong C, Tugwell P, Leslie K, Bullas R: A double-blind study of 250 cases comparing cemented with cementless total hip arthroplasty. Cost effectiveness and its impact on health-related quality of life. Clin Orthop 1994, 298:156-164.
9. Laupacis A, Bourne R, Rorabeck C, Feeny D, Wong C, Tugwell P, Leslie K, Bullas R: The Effect of Elective Total Hip Replacement Upon Health-Related Quality of Life. J Bone Joint Surgery 1993, 75:1619-1626.
10. Feeny D, Wu L, Eng K: Comparing Short Form 6D, standard gamble, and Health Utilities Index Mark 2 and Mark 3 utility scores: results from total hip arthroplasty patients. Qual Life Res 2004, 13:1659-1670.
11. Mahon JL, Bourne R, Rorabeck C, Feeny D, Stitt L, Webster-Bogaert S: Health-related quality of life and mobility in patients awaiting elective total hip arthroplasty in a prospective study. CMAJ 2002, 167:1115-1121.
12. Revicki DA, Osoba D, Fairclough D, Barofsky I, Berzon R, Leidy NK, Rothman M: Recommendations on health-related quality of life research to support labeling and promotional claims in the United States. Qual Life Res 2000, 9:887-900.
13. Feeny D, Juniper EF, Ferrie PJ, Griffith LE, Guyatt G: Why not just ask the kids? Health-related quality of life in children with asthma. In Measuring Health-Related Quality of Life in Children and Adolescents Implications for Research and Practice Edited by: Drotar D. Mahwah, NJ: Lawrence Erlbaum Associates Publishers; 1998:171-185.
14. Grootendorst P, Feeny DH, Furlong W: Does it matter whom and how you ask? Inter- and intra-rater agreement in the Ontario Health Survey. J Clin Epidemiol 1997, 50:127-136.
15. Raynauld JP, Torrance GW, Band PA, Goldsmith CH, Tugwell P, Walker V, Schultz M, Bellamy N, Canadian Knee OA Study Group: A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 1 of 2): clinical results. Osteoarthritis Cartilage 2002, 10:506-517.
16. Torrance GW, Raynauld JP, Walker V, Goldsmith CH, Bellamy N, Band PA, Schultz M, Tugwell P, Canadian Knee OA Study Group: A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 2 of 2): economic results. Osteoarthritis Cartilage 2002, 10:518-527.
17. Bellamy N: Pain assessment in osteoarthritis: experience with the WOMAC osteoarthritis index. Semin Arthritis Rheumatol 1989, 18:14-17.
18. Hays RD, Morales LS: The Rand-36 measure of health-related quality of life. Ann Med 2001, 33:350-357.
19. Ware JE Jr: The SF-36 health survey. In Quality of Life and Pharmacoeconomics in Clinical Trials Second edition. Edited by: Spilker B. Philadelphia PA: Lippincott-Raven Press; 1996:337-345.
20. Torrance GW, Furlong W, Feeny D: Health utility estimation. Expert Rev Pharmacoeconomics Outcomes Res 2002, 2:99-108.
21. Hawthorne G, Richardson J: Measuring the value of program outcomes: a review of multiattribute utility measures. Expert Rev Pharmacoeconomics Outcomes Res 2001, 1:215-228.
22. Feeny DH, Torrance GW, Furlong WJ: Health Utilities Index. In Quality of Life and Pharmacoeconomics in Clinical Trials Second edition. Edited by: Spilker B. Philadelphia: Lippincott-Raven Press; 1996:239-252.
23. Furlong WJ, Feeny DH, Torrance GW, Barr RD: The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies. Ann Med 2001, 33:375-384.
24. Patrick DL, Bush JW, Chen MM: Methods for measuring levels of well-being for a health status index. Health Serv Res 1973, 8:228-245.
25. Kaplan RM, Anderson JP: The general health policy model: an integrated approach. In Quality of Life and Pharmacoeconomics in Clinical Trials Second edition. Edited by: Spilker B. Philadelphia: Lippincott-Raven Publishers; 1996:309-322.
26. Gold MR, Siegel JE, Russell LB, Weinstein MC, (Eds): Cost-Effectiveness in Health and Medicine New York: Oxford University Press; 1996.
27. CCOHTA (Canadian Coordinating Office for Health Technology Assessment): Guidelines for Economic Evaluation of Pharmaceuticals: Canada 21997 [http://www.ccohta.ca]. Ottawa: Canadian Coordinating Office for Health Technology Assessment
28. Drummond MF, O'Brien B, Stoddart G, Torrance GW: Methods for the Economic Evaluation of Health Care Programmes Second edition. Oxford: Oxford University Press; 1997.
29. NICE (National Institute for Clinical Excellence): Guidance for Manufacturers and Sponsors. NICE Technology Appraisals Process Series No. 1 2001 [http://www.nice.org.uk]. London: National Institute for Clinical Excellence
30. Torrance GW, Feeny D, Furlong W: Visual analog scales: do they have a role in the measurement of preferences for health states? Med Decis Making 2001, 21:329-334.
31. Last JM, (Eds): A Dictionary of Epidemiology New York: Oxford University Press; 1983.
32. Streiner DL, Norman GR: Health Measurement Scales: A Practical Guide to Their Development and Use Oxford: Oxford University Press; 1991.
33. Deyo RA, Diehr P, Patrick DL: Reproducibility and responsiveness of health status measures: statistics and strategies for evaluation. Control Clin Trials 1991, 12:142S-158S.
34. Husted JA, Cook RJ, Farewell VT, Gladman DD: Methods for assessing responsiveness: a critical review and recommendations. J Clin Epidemiol 2000, 53:459-468.
35. Liang MH, Fossel AH, Larson MG: Comparisons of five health status instruments for orthopedic evaluation. Med Care 1990, 28:632-642.
36. Farivar SS, Liu H, Hays RD: Half standard deviation estimate of the minimally important difference in HRQOL scores? Expert Rev Pharmacoeconomics Outcomes Res 2004, 4:515-523.
37. Aday LA: Designing and Conducting Health Surveys San Francisco: Jossey-Bass; 1989.
38. Jackson W: Research Methods: Rules for Survey Design and Analysis Scarborough, Canada: Prentice-Hall Canada Inc; 1988.
39. Woodward CA, Chambers LW, Smith KD: Guide to improved Data Collection in Health and Health Care Surveys Ottawa: Canadian Public Health Association; 1982.
40. Sudman S, Bradburn NM: Asking Questions: A Practical Guide to Questionnaire Design San Francisco: Jossey-Bass; 1982.
41. Dillman DA: Mail and Telephone Surveys: The Total Design Method New York: Wiley and Sons; 1978.
42. Erdos PL: Professional Mail Surveys New York: McGraw-Hill; 1978.
43. Champion DJ, Sears AM: Questionnaire response rate: a methodological analysis. Soc Forces 1969, 47:335-339.
44. Seth J, Roscoe AM: Impact of questionnaire length, follow-up methods and geographic location on response rate to a mail survey. J Appl Psychol 1975, 60:252-254.
45. Stevenson AD, Birch PH, Friedman JM, Viskochil DH, Balestrazzi P, Boni S, Buske A, Korf BR, Niimura M, Pivnick EK, Schorry EK, Short PM, Tenconi R, Tonsgard JH, Carey JC: Descriptive analysis of tibial pseudoarthrosis in patients with neurofibromatosis type 1. Am J Med Genet 1999, 84:413-419.
46. Crawford AH, Schorry EK: Neurofibromatosis in children: the role of the orthopaedist. J Am Acad Orthop Surg 1999, 7: 17-230.
47. Clementi M, Milani S, Mammi I, Boni S, Monciotti C, Tenconi R: Neurofibromatosis type 1 growth charts. Am J Med Genet 1999, 87:317-323.
48. Friedman JM: Epidemiology of neurofibromatosis type 1. Am J Med Genet (Sem Med Genet) 1999, 89:1-6.
49. Ozonoff S: Cognitive impairment in neurofibromatosis type 1. Am J Med Genet (Sem Med Genet) 1999, 89:45-52.
50. Wolkenstein P, Zeller J, Revuz J, Ecosse E, Leplége A: Quality of life impairment in neurofibromatosis type 1. Arch Dermatol 2001, 137:1421-1425.
51. QOLID, the Quality of Life Instruments Database [http://www.qolid.org]
52. Medical Outcomes Trust, Scientific Advisory Committee: Assessing Health Status and Quality-of-Life Instruments: Attributes and Review Criteria. Qual Life Res 2002, 11:193-205.
53. Hufford MR, Shiffman S: Methodological issues affecting the value of patient-reported outcomes data. Expert Rev Pharmacoeconomics Outcomes Res 2002, 2:119-128.
54. Sintonen H: An approach to measuring and valuing health states. Soc Sci Med 1981, 15:55-65.
55. Rabin R, de Charro F: EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001, 33:337-343.
56. Hawthorne G, Richardson J, Osborne R: The Assessment of Quality of Life (AqoL) instrument: a psychometric measure of health-related quality of life. Qual Life Res 1999, 8: 09-224.
57. Brazier J, Roberts J, Deverill M: The estimation of a preference-based measure of health status from the SF-36. J Health Econ 2002, 21:271-292.
58. Brazier JE, Roberts J: The estimation of a preference-based measure of health from SF-12. Medical Care 2004, 42:851-859.
59. Torrance GW, Feeny DH, Furlong WJ, Barr RD, Zhang Y, Wang Q: Multi-attribute preference functions for a comprehensive health status classification system: Health Utilities Index Mark 2. Med Care 1996, 34:702-722.
60. Feeny D, Furlong W, Torrance GW, Goldsmith CH, Zhu Z, DePauw S, Denton M, Boyle M: Multi-attribute and single-attribute utility functions for the Health Utilities Index Mark 3 system. Med Care 2002, 40:113-128.
61. UCSD: Health Outcomes Assessment Program. http://medicine.ucsd.edu/fpm/hoap/qwb.htm and http://medicine.ucsd.edu/fpm/hoap/qwbsa.htm
62. Feeny D, Blanchard C, Mahon JL, Bourne R, Rorabeck C, Stitt L, Webster-Bogaert S: Comparing community-preference based and direct standard gamble utility scores: evidence from elective total hip arthroplasty. Int J Technol Assess Health Care 2003, 19: 62-372.
63. Feeny D, Furlong W, Saigal S, Sun J: Comparing directly measured standard gamble scores to HUI2 and HUI3 utility scores: group and individual-level comparisons. Soc Sci Med 2004, 58: 99-809.
64. Horsman JR, Furlong WJ, Feeny DH, Torrance GW: The Health Utilities Index (HUI®): concepts, measurement properties and applications. Health Qual Life Outcomes 2003, 1:54.
65. Health Utilities Inc./Health-Related Quality of Life [http://www.healthutilities.com]
66. Health Utilities Group/Health Utilities Index and Quality of Life [http://www.fhs.mcmaster.ca/hug]
67. Nathan PC, Furlong W, Horsman J, Van Schaik C, Rolland M, Weitzman S, Feeny D, Barr RD: Inter-observer agreement of a comprehensive health status classification system for pre-school children among patients with Wilms' tumor or advanced neuroblastoma. Qual Life Res 2004, 13:1707-1715.
68. Saigal S, Rosenbaum P, Feeny D, Furlong W, Stoskopf B, Hoult L: Multi-attribute health status classification system for preschool children: Final Report to The Medical Council of Canada for Grant No. MA 12956. Hamilton, ON, McMaster University; 2000.
69. Saigal S, Rosenbaum P, Stoskopf B, Hoult L, Furlong W, Feeny D, Hagan R: Development, reliability and validity of a new measure of overall health for pre-school children. Qual Life Res in press.
70. EuroQol Group [http://www.euroqol.org]
71. Ware JE Jr, Sherbourne CD: The MOS 36-item short-form health status survey (SF-36): I. conceptual framework and item selection. Med Care 1992, 30:473-483.
72. Ware JE, Snow KK, Kosinski M, Gandek B: SF-36 Health Survey manual and interpretation guide Boston: New England Medical Center, The Health Institute; 1993.
73. Wright JG: Quality of Life in Orthopedics. In Quality of Life and Pharmacoeconomics in Clinical Trials Second edition. Edited by: Spilker B. Philadelphia: Lippincott-Raven Press; 1996:1039-1044.
74. Fekkes M, Theunissen NCM, Brugman E, Veen S, Verrips EGH, Koopman HM, Vogels T, Wit JM, Verloove-Vanhorick SP: Development and psychometric evaluation of the TAPQOL: a health-related quality of life instrument for 1-5-year-old children. Qual Life Res 2000, 9: 61-972.
75. Uniform Data System for Medical Rehabilitation [http://www.udsmr.org]
76. Medical Outcomes Trust: Instruments [http://www.outcomestrust.org/instruments.htm]
77. The PedsQL™ Measurement Model for the Pediatric Quality of Life Inventory™ [http://www.pedsql.org]
78. Varni JW, Seid M, Kurtin PS: PedsQL™ 4.0: reliability and validity of the Pediatric Quality of Life Inventory Version 4.0 Generic Core Scales in healthy and patient populations. Med Care 2001, 39:800-812.
79. Varni JW, Burwinkle T, Seid M, Zellner J: The PedsQL as a population health measure: implications for states and nations. Quality of Life Newsletter 2002, 28:4-6.
80. Haynes RJ, Sullivan E: The Pediatric Orthopaedic Society of North America Pediatric Orthopaedic Functional Health Questionnaire: an analysis of normals. J Pediatr Orthop 2001, 21:619-621.
81. Young NL, Williams JI, Yoshida KK, Bombardier C, Wright JG: The context of measuring disability: does it matter whether capability or performance is measured? J Clin Epidemiol 1996, 49: 097-1101.
82. Young NL, Williams JI, Yoshida KK, Wright JG: Measurement properties of the Activities Scale for Kids. J Clin Epidemiol 2000, 53:125-137.
83. Vitale MG, Levy DE, Johnson MG, Gelijns AC, Moskowitz AJ, Roye BP, Verdisco L, Roye DP: Assessment of quality of life in adolescent patients with orthopaedic problems: are adult measures appropriate? J Pediatr Orthop 2001, 21:622-628.
84. Eiser C, Morse R: The measurement of quality of life in children: past and future perspectives. J Dev Behav Pediatr 2001, 22:248-256.
85. Connolly MA, Johnson JA: Measuring quality of life in paediatric patients. Pharmacoeconomics 1999, 16:605-625.
86. Pickard AS, Topfer LA, Feeny DH: A structured review of studies on health-related quality of life and economic evaluation in pediatric acute lymphoblastic leukemia. J Natl Cancer Inst Monogr 2004, 33:102-125.
87. Vitale MG, Levy DE, Moskowitz AJ, Gelijns AC, Spellman M, Verdisco L, Roye DP: Capturing quality of life in pediatric orthopaedics: two recent measures compared. J Pediatr Orthop 2001, 21:629-635.
88. Daltroy LH, Liang MH, Fossel AH, Goldberg MJ, the Pediatric Outcomes Instrument Development Group: The PONSA Pediatric Musculoskeletal Functional Health Questionnaire: report on reliability, validity, and sensitivity to change. J Pediatr Orthop 1998, 18:561-571.
89. Novacheck TF, Stout JL, Tervo R: Reliability and validity of the Gillette Functional Assessment Questionnaire as an outcome measure in children with walking disabilities. J Pediatr Orthop 2000, 20:75-81.
90. Grootendorst P, Feeny D, Furlong W: Health Utilities Index Mark 3: evidence of construct validity for stroke and arthritis in a population health survey. Med Care 2000, 38:290-299.